← Leaderboards
Ian Myles
National Institute Of Allergy And Infectious Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute Of Allergy And Infectious Diseases
Same institution · by research overlap
Others in their field
Top investigators on “T Memory Cell”
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Rafi Ahmed · Emory University$68,625,488
- David A Bennett · Rush University Medical Center$57,993,832
- Peter Scott Heeger · Case Western Reserve University$56,751,512
- Joren C Madsen · Massachusetts General Hospital$41,298,694
- Rafick-Pierre Sekaly · University Of Montreal$41,246,164
Research focus
T Memory CellResponseMucous MembraneImmuneReportingCd8b1 GeneAntigensPeptidesMemoryHybridsMorphologic ArtifactsAnalytical ChemistryCellular ImmunityTransfer FactorInterleukin-6TuberculosisPhysiologyInfectionAdaptive Immune ResponseImmune ResponseBacterial InfectionsBacteriaHost-Microbe InteractionsImmunity
Grant awards (20)
Host Immunity Against Bacteria$1,517,349
ZIA · FY2025 · AI · contact PI
Use of Transfer Factor as a Novel Immune Therapeutic$79,861
ZIA · FY2025 · AI · contact PI
Host Immunity Against Bacteria$1,652,722
ZIA · FY2024 · AI · contact PI
Use of Transfer Factor as a Novel Immune Therapeutic$86,987
ZIA · FY2024 · AI · contact PI
Host Immunity Against Bacteria$1,516,128
ZIA · FY2023 · AI · contact PI
Use of Transfer Factor as a Novel Immune Therapeutic$79,798
ZIA · FY2023 · AI · contact PI
Host Immunity Against Bacteria$1,427,388
ZIA · FY2022 · AI · contact PI
Use of Transfer Factor as a Novel Immune Therapeutic$75,129
ZIA · FY2022 · AI · contact PI
Host Immunity Against Bacteria$2,586,554
ZIA · FY2021 · AI · contact PI
Use of Transfer Factor as a Novel Immune Therapeutic$456,452
ZIA · FY2021 · AI · contact PI
Host Immunity Against Bacteria$985,803
ZIA · FY2020 · AI · contact PI
Use of Transfer Factor as a Novel Immune Therapeutic$173,966
ZIA · FY2020 · AI · contact PI
TNFR-Nicotinic Signaling in COVID-19$12,447
ZIA · FY2020 · AI · contact PI
Host Immunity Against Bacteria$9,773
ZIA · FY2019 · AI · contact PI
Use of Transfer Factor as a Novel Immune Therapeutic$1,086
ZIA · FY2019 · AI · contact PI
Host Immunity Against Bacteria$420,230
ZIA · FY2018 · AI · contact PI
Use of Transfer Factor as a Novel Immune Therapeutic$8,576
ZIA · FY2018 · AI · contact PI
Use of Transfer Factor as a Novel Immune Therapeutic$432,768
ZIA · FY2017 · AI · contact PI
Use of Transfer Factor as a Novel Immune Therapeutic$561,243
ZIA · FY2016 · AI · contact PI
Use of Transfer Factor as a Novel Immune Therapeutic$164,629
ZIA · FY2015 · AI · contact PI